Delivery Order SPE2DB22D3301-SPE2DB25FY4DB
Award Date
5/1/25
Potential Completion Date
5/22/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,630.28, is for the delivery of OFEV 100 MG CAPSULE 60S, a pharmaceutical product, with a performance period ending on May 6, 2025. The contract is a firm fixed-price delivery order and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,915.84 and covers the delivery of OFEV 100 MG CAPSULE 60S, a prescription medication, through July 15, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.58, is for the delivery of OFEV 150 MG capsules over a period ending on February 19, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,630.28, is for the supply of OFEV 100 MG CAPSULE 60S, a specialty medication. The contract has an ultimate completion date of April 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4556014165 OFEV 100 MG CAPSULE 60S. The $5,818.36 firm fixed-price contract has an ultimate completion date of February 11, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,181.16, is for the delivery of OFEV 150 MG CAPSULE 60S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,771.74, is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,630.28, is for the delivery of OFEV 100 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of May 5, 2025 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $7,905.56 firm-fixed-price contract is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product, to support the agency's medical requirements. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite-delivery contracts (IDCs) with the DLA and other...
This is a delivery order award to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $7,915.84 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of OFEV 100 MG CAPSULE 60S. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...